Product Images Pregabalin

This is a set of label descriptions for different presentations of Pregabalin Capsules 100mg from Enovachem, a pharmaceutical company. The text includes the National Drug Code (NDC) and other details such as package quantity, Drug Status, and source number.*

Description: This text contains information about Pregabalin Capsule 200mg with NDC code 76420-122-90. The capsule is orange opaque and has LA#S written on it. The text also mentions the manufacturer, Rising Pharmaceuticals Inc., and the product's storage instructions. There is also information about other variants of the capsule with different NDC codes, quantities, and batch numbers.*

This is a list of Pregabalin Capsules with varying quantities and National Drug Codes (NDC) including details on the manufacturers and lots. There is not enough information to provide a more specific description.*

This appears to be a list of different versions of Pregabalin Capsules in 50mg dosages, including their NDC codes and some cautionary advice.*

The text shows a chart indicating the percent of patients improved after taking Pregabalin 160 mg for 3 days. The chart also shows the percent improvement in pain from baseline, with values ranging from 2 to 100. There appears to be some additional text, but it is unreadable due to errors.*

This appears to be a table showing various medications and their recommended dosages, as well as the percentage of patients who experienced pain improvement while taking them. However, the text is not fully readable and some parts are unclear, so a full and accurate description cannot be provided.*

This appears to be a partially readable clinical trial report evaluating the effects of Fregabalin and Pregataiin on pain relief in patients. The dosage and frequency of administration for each drug are given along with a placebo group. The "Percent Improvement in Pain from Baseline" is also provided, but it is difficult to ascertain the validity of the results due to the unreadable characters and incomplete data.*

This text appears to be a chart showing the different doses of Pregabalin and their effectiveness in improving pain. The chart displays the results in percentages, but the labels and units for the axes are not available.*

This text contains a table displaying percentages of subjects without LTR based on the use of Pregabalin and Placebo medication, along with a timeline of 12 days. It is not possible to determine the context or purpose of this information with only the given text.*

The text shows the percentage of subjects who improved after taking Pregabalin compared to Placebo after 16 weeks. The percentage of improvement ranges from 100 to 280 percent.*